Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

Indinavir * Infant 95

12th World AIDS Conference

Keyword

Abstract--

Keyword

Abstract--

ng (XL) of CD4 T cells/ Indirect mechanism of bystander cell deat 274*/21159
eyond needle sharing: " " sharing and viral infections amon 23352
nada: Using direct and methods with Monte Carlo simulat 43475
eriod in 1996-1997: An evidence through a back-calculati 43480
olving surveillance tool/ Individual case reporting (ICR) of HIV infe 43434
dents/Sexual behavior, STD prevention, and self report 13500
gressing HIV-1 infected /Recognition of two overlapping 31135
g the population on the familial and community taking i 33511
ach one teach one: The and community-wide impact of 33556
ups in India/Social and constraints underlying the emer 43337
tfalls of methodological individualism in HIV epidemiology/The q 24157
HIV/AIDS: Designing an individualized experience/Mini-residency 60931
stogram in HIV positive individuals /Late potentials based on insta 12112

e/HIV infection among from North African attending a
ells from seropositive is antigen processing-depend
rtners of HIV-1 infected /Detection of HIV-1 infection b
hy adult HIV-1 infected /Chronic use of protease inhibi
BMC of HIV-1 infected: Longitudinal analyses from th
a (PCP) in HIV-infected /Failure of prophylaxis for Pne
rculosis in HIV positive: Isoniazid vs. rifabutin/Multina
ed from a kind of plants, Indocalamus, in vitro/Anti-human immun

n HIV-infected African
y virus type 1 - Infected
r (NFV) in HIV-infected
CFU-Cs in HIV-infected
3TC) in HIV-1 infected
utreach to HIV infected
sorders in HIV-positive
nsmission among male
sion in a cohort of HIV+
heterosexually infected
pisodes in HIV infected
elated diseases among
h cohort of HIV infected
on of HIV-1 infection in
mon factors facilitating
haviour of HIV-infected
al blood of HIV infected
ers of HIV-seropositive
g T cells of HIV infected
cally immune activated
hocytes of HIV-infected
ed health threat to HIV+
sis among HIV-infected
e and HIV seronegative
cessary in HIV positive
i in adult HIV-1 infected
e of STD in HIV-positive
navir in HIV-1 infected
RT) in 25,000 HIV/AIDS
erapy in HIV-1-infected
vention for HIV-positive
I transmission of HIV to
ection in transgendered
ion to care HIV infected
DS-free HIV-1 infected
ne response in Brazilian
2 exposed non-infected
posed, uninfected (EU)
IV-exposed uninfected
s (PBMCs) from HIV-2+
onuclear neutrophils of
mphocytes of HIV-1(+)
cytes from HIV-infected
HHV-8 in HIV-1 positive
asma of HIV-1 infected
dy composition in HIV+
ehyde in HIV-1 infected
ells from HIV-1 infected
ns and plasma of HIV+
triculitis in HIV-infected
ng Filipino HIV-infected
ug-resistant variants in
ling/Characteristics of
the effects of providing
ve of five HIV+ affected
memory T cells in HIV+
reaction in HIV-infected
cells from HIV-infected
BMC from HIV-Infected
onitoring HIV-1 positive
d drugs by HIV infected
ng emotional distress in
eral neuropathy in HIV+
in Puerto Rico?/Which
ng among HIV infected
nerve in HIV-1-infected
a amongst HIV infected: Immunologic, phenotypic and
from Bolivia reveals presence
/Study of protease inhibitor co
upon commencement of comb
/An open-label randomized st
living in SRO hotels/Results o
-The subjective perception/N
aged 17, in Brazil/Knowledge
diagnosed in 1986 in Cuba/Di
in The Netherlands/HIV-1 sub: Is there a need for secondary
with known dates of HIV seroc
/Chemokine receptor CCR2b
treated in an emergency servi
to have access to STD care an
/Effects of isolation under the
/HIV infected CD4+ syncytia a
/Serum HIV neutralizing activit
/CD80 and CD86 adhesion m
/Increased susceptibility to HI

12147
12178
290*/12222
12323
12357
12447
12449
13159
13167
13195
612*/13277
13310
13327
13394
13482
14268
21111
21124
21125
21156

f HIV/AIDS epidemic in Indonesia
ransvestites in Jakarta,
ale sex workers in Bali,
ong sex workers in Bali,
are and prevention in
native healers group in
in brothel complexes in
outh at high risk in Bali,
ale sex workers in Bali,
s program in Surabaya,
e to HIV/AIDS impact in

S/Current situation and trend of H
/HIV prevalence and risk behavi
/AIDS/STD knowledge, prevent
/Sensitivity and specificity of sy
/Role of people living with HIV/A
/Developing a community base: Lesson learned from the Kram
/Implementation of pre and post
/AIDS/STD knowledge, prevent
/Risk profile of female sex work
/Islamic response to HIV/AIDS i

60257
60414
60529
60648
60796
60797
60858
41207
13150
23131
23523
79*/33235
34249
43172
43268
43538
60168
60355
60628: Comparison with interleukins- 280*/21162
in developing countries?/Heli 22115
in Belo Horizonte, Brazil: A ca 22141
in Pune, India/Clinical present 22150
responding to antiretroviral th 22175
with stable CD4 cell count abo 22179
in Honduras, Central America, 22206
/Plasma viral load reduction in 22393
in Mumbai, India/Scenario of 22406
heterozygous for CCR5A32/I 22419
experiencing symptoms/Ran 22458
without risk factors within the 23374
in San Francisco/Prevalence 23536
at workplace/Apprehension to 24308
/Neutralizing antibodies again 31109
infected with different HIV-1 st 31117
in Guinea-Bissau/Increased I 605*/31133
/Enhanced production of mon 31140
appears to be mediated by a C 31143
resist in vitro infection with ma 31154
infected with HIV-1 and Mycob 31167
/Coexpression of CD69 and C 31181
/rlL-2 rescues in vitro function 31185
and normal blood donors from 31192
/High detection rate of HGV in 32101
without wasting who initiate m 32183
and patients with AIDS/Urinar 32187
induce apoptosis of primary n 32200
and HIV- controls with and wit 32210
in Russia/Cases of dementia 32225
at San Lazaro Hospital, Manil 32253
with primary HIV-1 infection/F 228*/32280

and sexual networks of Indonesian migrant workers in Malaysia/ 23580
V-1 infected individuals induce apoptosis of primary neurons/Infla 32200
perinatal transmission/ Induced P-chemokine and cytokine respo 23279
(TX) of nelfinavir (NFV) diarrhea (NFVID)/The treatment 12383
evelopment of indinavir renal stones/Evaluation of urinar 12394
ell death of CD8 T cells by CD4 crosslinking (XL) of CD4 274*/21159
tion markers/Therapy reduction in plasma virus load lea 21163
unit boost/CD8 + CTL in AIDS vaccine evaluation group 495*/21192
V-1 isolates by antisera upon immunization with a recomb 550*/21194
cell mediated immunity by a consecutive HIV-1 DNA and 549*/21198
/Evidence that HAART immune recovery vitritis in CMV r 15*/22240
undetectable HIV RNA by combination antiretroviral ther 22377
ytotoxic T lymphocytes by DNA immunization/SIV-specif 31145
eceptor on HIV rgpl20- B lymphocyte function/Role of p- 31159
iated HIV killing activity by Echinacea angustifolia/Dram 32309
t of human interferon-P by HIV infection after gene transf 41250
d hormone is the major inducer of CD4+ T cell death in HIV-1-infe 21160
/The HIV-1 Nef protein induces CD4+ T-cell apoptosis through fu 11145
egion of SIV envelope strong cellular immune response 11241
ed cells/HIV-1 infection alterations in cellular gene expres 21152
ghly immunogenic and neutralizing antibodies in macaqu 21216
e through infotainment/ Inducing pivotal decision makers in effecti 43301
rus-associated epitope antibody responsible for the non- 41111
follow-up of syncytium strains in HIV patients under anti 42192
1 subtype C syncytium (SI) phenotype among Ethiopian 60879
ly results/ADAM study. Induction-maintenance therapy in HIV-1 i 12229
t antiretroviral therapy/ Induction of HIV-1 replication by influenza 21113
e-tropic HIV envelope/ of phosphorylation and associat 55*/21135
y dosing of ganciclovir/ treatment of CMV: A compariso 22267
athogen free chickens/ of specific anti-HIV-1 IgY produ 41239
le receptor chemotaxis by HIV-1 envelope/Actin depen 11120
t canarypox virus/CTL in macaques using intravenous i 11243
osal inoculations/AIDS in rhesus monkeys with a mutan 11244
on antiretroviral therapy /Patterns of nausea with combin 12402
mokine receptors in the of interferon by HIV-1/Involvem 21172
C class I restricted CTL /CD86 confers and directs and 21195
/In vitro HIV-1 antibody: Testing of the Shiloov tube/In v 41112
y tuberculosis/Sputum and ligase chain reaction as adj 41152
ces and HIV risk among industrial workers in South India/Sexual p 23416
ruckers in a port based zone/STD/HIV/AIDS interventi 33422
Peer education among workers at work place/Peer edu 33572
DS discrimination in an industrialised country, the case of Switzer 44170
the workplace in Indian industry confederation of Indian industry ( 13439

presenting for post-exposure
with risky behaviours with a ne
/Cherishing, repairing and gro: Cytokine producing lymphocy
/Modifications in the DTH reac
/Immunomodulatory effects of
after expansion in vitro/Conse
in community based settings/: A qualitative approach/Utiliza
who are HIV-positive/Reducin
/Massage therapy for the treat
undergo voluntary HIV serolo
in Uganda/Awareness, perce
under stavudine therapy/Elec
in Pune, India/Seroprevalenc

33173
33285
34131
216*/41103
41124
41244
41249
42156
42307
42374
42376
138*/43121
43344
60023
60091

ntervention in trucking
outh Africa's goldmining
en in the entertainment
ty and pharmaceutical
he Philippines maritime
S, India and the trucking
kers on Indian trucking
impact on the male sex
DS/A unique Zululand
many "faces" of the sex

/Workplace intervention in truckin 13451
/An intervention trial in South Afri 33536
in Davao City, Philippines: An ass 34295
in Canada working in partnership 42238
/Prospects for HIV/AIDS/STD pre 44192
/AIDS, India and the trucking 541*/44200
/An assessment of socio-econom 44201
in Santo Domingo/A "gay paradi 44205
joint venture response to the nee 651*/44221
in Metro Manila/Outreach and th 60819

s trypanocidal therapy ineffective /Co-infection of vervet monkey
atment with ganciclovir/ Ineffectivity of cidofovir in treating AIDS-r
go, Illinois, USA- 1996/ Inequalities in declining HIV-related morta
s living with HIV/Racial in the receipt of HIV/AIDS-rel
ns working to overcome /Progress through partnershi
Journal on the Internet: inexpensive, wide, global and cost-effecti
with a simple, non-toxic, combination of didanosine pl
ices in the Women and Infant Transmission Study (WITS): Pre an

11229
60659
94*/43433
44166
44267
34379
41180
13565